Case Study: Scaling Corganics with Founder-Led Storytelling

Client Overview

Company: Corganics

Industry: Healthcare, Pain Management

Audience: Physicians, healthcare administrators, surgical teams, and rehab specialists

The Challenge

Corganics produces clinically trusted CBD products aimed at providing a safe, non-opioid alternative for pain management after surgery. While the products are backed by rigorous science—Advanced Lipid Technology, IRB approval, third-party testing—the company faced significant communication barriers:

• Limited reach beyond one-on-one physician conversations
• Overly polished marketing that lacked authenticity
• Founders too focused on innovation to maintain high-volume media production

In a high-trust, time-constrained healthcare environment, traditional marketing was failing to connect.

The Strategic Opportunity

The healthcare market is at a tipping point in the shift toward opioid alternatives:

• 130+ opioid-related deaths occur daily in the U.S., with ~40% tied to prescriptions
• Hospitals adopting multimodal analgesia are reducing opioid use by up to 50%
• The global opioid alternatives market was valued at $15.8B in 2024, projected to double by 2033

Corganics needed a way to scale authentic, credible messaging to capitalize on this momentum.

Campaign Execution

UGC as the Trust Multiplier:MarketScale’s model enabled the CEO and clinical founders to appear direct-to-camera, telling their story in their own words. This approach humanized the brand, cut through skepticism, and resonated with healthcare decision-makers.

Scalable Distribution:Content was placed where it would have the most impact:

• LinkedIn for peer-to-peer credibility
• Industry verticals focused on non-opioid solutions
• Digital hubs for surgeons, pain specialists, and rehab teams

Data-Driven Refinement:Real-time analytics identified the most resonant messages, guided adjustments for different specialties, and prioritized content for replication.

Impact & Industry Metrics

• Expanded Reach: Grew audience from early-adopter physicians to entire healthcare networks.
• Increased Demand: More inbound inquiries from surgical teams and rehab centers.
• Higher Engagement: UGC outperformed static content in click-through and watch rates, driven by authenticity and relatability.

Strategic Advantages

ChallengeTraditional ApproachCorganics’ UGC ApproachCredibility in HealthcarePolished, corporate marketingFounder-led, clinician-to-clinician storytellingAudience ReachLimited to in-person meetingsScaled to national networksSpeed to MarketSlow, production-heavy processesRapid content creation and deploymentMessage ResonanceGeneric product claimsClinical, human-centered narratives

Lessons & Recommendations

• Lead with Authenticity: Founder voices carry more weight than scripted marketing in healthcare.
• Prioritize Distribution: Reaching the right audience is as important as crafting the right message.
• Refine with Data: Use analytics to double down on what resonates most with your audience.

Conclusion

Through founder-led storytelling, targeted distribution, and continuous data refinement, Corganics turned its mission into a scalable, national conversation. At a time when the healthcare industry is actively seeking safer, clinically trusted pain management solutions, this approach positioned Corganics as a trusted leader and change-maker.